Clinical Laserthermia Systems AB (publ)

CLS-B.ST

CLS-B.STClinical Laserthermia Systems AB (publ) SE flag

Stockholm Stock Exchange

2.90

SEK

-0.14

(-4.61%)

-4.30EPS

-0.67P/E

58.03MMarket Cap

May 16Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

SE0002756130

Return %

Stock

S&P500

-80.77

18.57

-99.44

40.07

-99.76

86.07

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	- -	- -	- -	- -	- -	- -	1.03	2.69	2.01	1.53	2.44	14.48	2.37	1.61
Basic EPS, GAAP	-25.73	-34.61	-46.72	-46.22	-36.12	-54.5	-35.5	-48.84	-61.23	-66.41	-69.24	-163.22	-22.89	-5.54
Free Cash Flow per Basic Share	-28.59	-38.45	-53.13	-47.04	-44.78	-42.81	-48.52	-3.53	- -	-0.4	-0.6	-1.3	-1.58	-0.54
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-50.66	-71.15	-112.69	-160.71	-170.63	-212.41	-215.32	-243.04	-292.27	-301.56	-349.84	-135.86	9.3	2.14
Tangible Book Value per Share	3.29	14.62	30.37	38.81	2.11	-6	15.49	35.31	-23.6	-8.39	1.73	-22.64	7.07	3.3
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	1	1	1	1	1	- -	3	12
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	1	2	1	1	2	6	8	19
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-3,388.17	-1,845.47	-2,967.53	-3,889.7	-2,699.98	-1,075.95	-791.51	-319.46
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	3	3	3	2	3	3
Net Income, GAAP	-7	-13	-18	-18	-17	-27	-21	-33	-43	-58	-64	-71	-80	-64
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-3,463.03	-1,817.2	-3,041.73	-4,349.77	-2,833.63	-1,127.31	-964.49	-344.68
Working Capital	1	5	12	15	1	-3	10	24	-19	-9	-3	-17	13	21
LT Debt	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -
Total Equity	11	17	26	32	19	17	33	50	7	14	21	8	44	58
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-167.87

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	50.4%	31.99%
Net Income, GAAP	18.56%	19.88%	12.92%
Free Cash Flow	- -	- -	878.11%
Total Cash Common Dividend	- -	- -	- -
Total Equity	57.04%	91.16%	453.44%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Dan Johansson Mogren
Full Time Employees: 17
Sector: Healthcare
Industry: Medical - Devices
Address: Building 405 Lund Sweden 223 81
IPO Date: Apr 16, 2009
Website: clinicallaser.se
Similar Companies: InMode Ltd. (INMD)
DIH Holdings US, Inc. Class A Common Stock (DHAI)
Nexeon MedSystems Inc. (NXNN)
BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)
Carmat SA (ALCAR.PA)
Lutronic Corporation (085370.KQ)
Business: Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

	Mar'24	Jun'24	Sep'24
Total Current Assets	28	25	31
Accounts Receivable, Net	3	6	6
Cash, Cash Equivalents & STI	16	12	16
Inventories	2	2	2
Total Current Liabilities	11	22	10
Payables & Accruals	- -	- -	- -
ST Debt	- -	- -	- -
Deferred Revenue	- -	- -	- -

	Mar'24	Jun'24	Sep'24
ST Debt	- -	- -	- -
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	8	14	14
Market Capitalization	88	53	61

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	- -	- -	- -	- -	- -	- -	1.03	2.69	2.01	1.53	2.44	14.48	2.37	1.61
Basic EPS, GAAP	-25.73	-34.61	-46.72	-46.22	-36.12	-54.5	-35.5	-48.84	-61.23	-66.41	-69.24	-163.22	-22.89	-5.54
Free Cash Flow per Basic Share	-28.59	-38.45	-53.13	-47.04	-44.78	-42.81	-48.52	-3.53	- -	-0.4	-0.6	-1.3	-1.58	-0.54
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-50.66	-71.15	-112.69	-160.71	-170.63	-212.41	-215.32	-243.04	-292.27	-301.56	-349.84	-135.86	9.3	2.14
Tangible Book Value per Share	3.29	14.62	30.37	38.81	2.11	-6	15.49	35.31	-23.6	-8.39	1.73	-22.64	7.07	3.3
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	1	1	1	1	1	- -	3	12
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	1	2	1	1	2	6	8	19
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-3,388.17	-1,845.47	-2,967.53	-3,889.7	-2,699.98	-1,075.95	-791.51	-319.46
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	3	3	3	2	3	3
Net Income, GAAP	-7	-13	-18	-18	-17	-27	-21	-33	-43	-58	-64	-71	-80	-64
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-3,463.03	-1,817.2	-3,041.73	-4,349.77	-2,833.63	-1,127.31	-964.49	-344.68
Working Capital	1	5	12	15	1	-3	10	24	-19	-9	-3	-17	13	21
LT Debt	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -
Total Equity	11	17	26	32	19	17	33	50	7	14	21	8	44	58
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-167.87

Year	Q1	Q2	Q3	Q4	FY
2022	-13.15	-15.65	-15.11	- -	-163.22
2023	-8.18	-6.34	-3.3	- -	-22.89
2024	-1.64	-0.98	-0.98	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	1	- -	1	4	6
2023	1	1	2	4	8
2024	3	6	5	- -	- -

Clinical Laserthermia Systems AB (publ)

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year